Researchers conducted a small experimental study to see if Vitamin D could affect a specific protein in people with chronic obstructive pulmonary disease (COPD). They gave five stable COPD patients at a single hospital a daily dose of 5000 IU of Vitamin D for three months. They measured levels of Vitamin D in the blood, a protein called HDAC2 (which is involved in inflammation), and standard tests of lung function.
After three months, the patients' Vitamin D levels and their HDAC2 levels both increased significantly. However, the tests of lung function, like how much air they could exhale, only showed a slight increasing trend. This change in lung function was not large enough to be considered statistically significant, meaning it could have happened by chance.
The main reason to be careful with these results is that the study was very small, with only five patients. A study this small cannot tell us if Vitamin D is safe or helpful for most people with COPD. The increase in HDAC2 suggests Vitamin D might have an anti-inflammatory effect, but we do not know if that translates to any real-world benefit like easier breathing or fewer flare-ups. Readers should realistically take from this that early research is exploring a possible biological link, but much larger and longer studies are needed before any conclusions can be drawn about using Vitamin D for COPD.
